Tendo M - Search Results

1

A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.

Kawajiri H, Yashiro M, Shinto O, Nakamura K, Tendo M, Takemura S, Node M, Hamashima Y, Kajimoto T, Sawada T, Ohira M, Hirakawa K. Kawajiri H, et al. Among authors: tendo m. Clin Cancer Res. 2008 May 1;14(9):2850-60. doi: 10.1158/1078-0432.CCR-07-1634. Clin Cancer Res. 2008. PMID: 18451253

2

Novel models for human scirrhous gastric carcinoma in vivo.

Takemura S, Yashiro M, Sunami T, Tendo M, Hirakawa K. Takemura S, et al. Among authors: tendo m. Cancer Sci. 2004 Nov;95(11):893-900. doi: 10.1111/j.1349-7006.2004.tb02199.x. Cancer Sci. 2004. PMID: 15546507 Free PMC article.

3

Effect of organ-specific fibroblasts on proliferation and differentiation of breast cancer cells.

Yashiro M, Ikeda K, Tendo M, Ishikawa T, Hirakawa K. Yashiro M, et al. Among authors: tendo m. Breast Cancer Res Treat. 2005 Apr;90(3):307-13. doi: 10.1007/s10549-004-5364-z. Breast Cancer Res Treat. 2005. PMID: 15830145

4

[Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer].

Tendo M, Nakata B, Nishino H, Inoue M, Kosaka K, Amano R, Yamada N, Hirakawa K. Tendo M, et al. Gan To Kagaku Ryoho. 2005 Jun;32(6):795-8. Gan To Kagaku Ryoho. 2005. PMID: 15984518 Clinical Trial. Japanese.

5

Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.

Tendo M, Yashiro M, Nakazawa K, Yamada N, Hirakawa K. Tendo M, et al. Cancer Sci. 2005 Jul;96(7):451-5. doi: 10.1111/j.1349-7006.2005.00066.x. Cancer Sci. 2005. PMID: 16053517 Free PMC article.

6

A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells.

Tendo M, Yashiro M, Nakazawa K, Yamada N, Sawada T, Ohira M, Hirakawa K. Tendo M, et al. Cancer Lett. 2006 Dec 8;244(2):247-51. doi: 10.1016/j.canlet.2005.12.019. Epub 2006 Jan 31. Cancer Lett. 2006. PMID: 16448745

7

Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.

Yashiro M, Nakazawa K, Tendo M, Kosaka K, Shinto O, Hirakawa K. Yashiro M, et al. Among authors: tendo m. Int J Cancer. 2007 Feb 1;120(3):686-93. doi: 10.1002/ijc.22329. Int J Cancer. 2007. PMID: 17096355

8

A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.

Nakamura K, Yashiro M, Matsuoka T, Tendo M, Shimizu T, Miwa A, Hirakawa K. Nakamura K, et al. Among authors: tendo m. Gastroenterology. 2006 Nov;131(5):1530-41. doi: 10.1053/j.gastro.2006.08.030. Epub 2006 Aug 22. Gastroenterology. 2006. PMID: 17101326

9

Comparison of clinicopathological characteristics of curatively resected pancreatic head and body/tail ductal cancers.

Nakata B, Yamada N, Amano R, Tendo M, Inoue M, Sakurai K, Hirakawa K. Nakata B, et al. Among authors: tendo m. J Exp Clin Cancer Res. 2007 Dec;26(4):459-66. J Exp Clin Cancer Res. 2007. PMID: 18365539

10

Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.

Yashiro M, Shinto O, Nakamura K, Tendo M, Matsuoka T, Matsuzaki T, Kaizaki R, Miwa A, Hirakawa K. Yashiro M, et al. Among authors: tendo m. Int J Cancer. 2010 Feb 15;126(4):1004-16. doi: 10.1002/ijc.24763. Int J Cancer. 2010. PMID: 19621385

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters